Registry of Arterial Hypertension

Arterial Hypertension Clinical Trial

Official title:

Registry of Arterial Hypertension: "Study of Modern Phenotypes of Arterial Hypertension, Including Secondary Forms, in Order to Create Personalized Methods of Treatment"

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04160533
• Other study ID #: 86
• Status: Recruiting
• Start date: June 1, 2018
• Est. completion date: December 2023

Study information

• Verified date: September 2022
• Source: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
• Contact: Anna Aksenova, MD
• Phone: +74954146186
• Email: aksenovaannav[@]gmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The problem of the quality of primary health care medical system for patients with arterial hypertension is acute for the investigator's country, as these diseases are the most common and cause the high mortality of the population.

The concept of "quality of primary health care medical system" includes its timeliness, accessibility and provision of medical care to the patient at the modern level, which is determined by the degree of performance by doctors of medical and diagnostic measures corresponding current clinical recommendations.

The system of cardiovascular desease registries, established in the Federal State Clinical Hospital of the Russian Federation Ministry of Public Health with the automated analysis of data on examination and treatment, in comparison with clinical Recommendations. It makes possibility to identify shortcomings and develop approaches to improving the provision of medical care to patients in real clinical practice.

Comparative analysis of the quality of examination and treatment in different samples of patients with cardiovascular desease, observed in 2018-2020, compared with results of previous years will identify ptrends in the provision of medical care to patients with cardiovascular desease.

Description:

The study will be conducted using the arterial hypertension registry method, which is a computer program with remote access that allows online collection medical data from medical primary care system. To minimize operator errors, doctors was trained before the work with the arterial hypertension registry. User's guide was developed and the rights of users was determined. Data of examination and treatment of patients from 18 years and older with an established diagnosis of hypertension will be added from outpatient cards into the registry of the arterial hypertension. The information is received by the Institution in an impersonal form through a certified dedicated security channel. Patients sign an informed consent for entering their medical data into the registry of arterial hypertension

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10400
• Est. completion date: December 2023
• Est. primary completion date: December 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria: The diagnosis of arterial hypertension -

Exclusion Criteria: No diagnosis of arterial hypertension

-

Related Conditions & MeSH terms

• Arterial Hypertension
• Hypertension

Locations

Country	Name	City	State
Russian Federation	Regional state budgetary institution of health care Altai Regional Cardiology Dispensary State budgetary institution of public health "Volgograd regional clinical hospital No. 1" clinic State budgetary health institution of the Kemerovo region "Kemerovo R	Barnaul	Altai
Russian Federation	State Healthcare Institution "Engels City Polyclinic No. 2	Engels
Russian Federation	State Healthcare Institution "Engels City Polyclinic No. 4	Engels
Russian Federation	State budgetary health institution of the Kemerovo region "Kemerovo Regional Clinical Cardiology Dispensary named after Academician L.S. Barbarash	Kemerovo
Russian Federation	State budgetary institution of the ryazan region "regional clinical cardiological dispensary"	Ryazan
Russian Federation	Municipal budgetary institution of public health "City polyclinic ?1" Taganrog Branch ?1	Taganrog
Russian Federation	Municipal budgetary institution of public health "City polyclinic ?1" Taganrog Branch ?2	Taganrog
Russian Federation	Municipal budgetary institution of public health "City polyclinic ?1" Taganrog Branch ?3	Taganrog
Russian Federation	Municipal budgetary institution of public health "City polyclinic ?1" Taganrog Branch ?4	Taganrog
Russian Federation	Municipal budgetary institution of public health "City polyclinic ?2" Taganrog Branch ?1	Taganrog
Russian Federation	Municipal budgetary institution of public health "City polyclinic ?2" Taganrog Branch ?4	Taganrog
Russian Federation	Municipal budgetary institution of public health services "City ambulance hospital" city of Taganrog	Taganrog
Russian Federation	State Autonomous Healthcare Institution of the Tyumen Region "Tyumen Institute of Therapy	Tyumen
Russian Federation	Municipal Health Institution "City Hospital No. 1" Volgodonsk	Volgodonsk
Russian Federation	Municipal health institution "City polyclinic ?1" Volgodonsk	Volgodonsk
Russian Federation	Municipal health institution "City polyclinic ?3" Volgodonsk	Volgodonsk
Russian Federation	State budgetary institution of public health "Volgograd regional clinical hospital No. 1" clinic	Volgograd

Sponsors (1)

Lead Sponsor	Collaborator
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients with blood pressure <140/90 mm Hg	The level of systolic and diastolic blood pressure measured according to the rules described in the clinical guidelines for the treatment and diagnosis of arterial hypertension of the European Society of Cardiology during the visit (mmHg) is entered into the database by doctors.	2018 - 2021 years
Secondary	Number of patients with a history of myocardial infarction, chronic renal desease, chronic heart failure, atrial fibrillation.	Diagnosis data is entered by doctors as a "yes" or "no" category.	2018-2021
Secondary	Antihypertensive medications	Antihypertensive drugs the patient takes are entered into the database. Drugs are analyzed by groups and daily dosages	2018-2021